H. Prentice

发表

Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis.

Dylan T. Jones, K. Ganeshaguru, Robert Anderson, 2003, Blood.

Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage‐induced apoptosis in B‐chronic lymphocytic leukaemia cells

M. Wadhwa, R. Thorpe, Dylan T. Jones, 2001, British journal of haematology.

DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTS

G. Janossy, H. Prentice, A. Hoffbrand, 1984, The Lancet.

The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia

H. Prentice, M. Lowdell, N. Ray, 1997, Bone Marrow Transplantation.

Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function – implications for the adoptive immunotherapy of leukaemia

H. Prentice, M. Lowdell, L. Barber, 2001, Clinical and experimental immunology.

Main Session III

H. Heslop, C. Rooney, C. Bollard, 2002, Annals of Hematology.

The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation

J. Madrigal, J. Goldman, H. Prentice, 2003, Bone Marrow Transplantation.

Cytotoxic effects of tumour necrosis factor and gamma-interferon on acute myeloid leukaemia blasts.

H. Prentice, M. Brenner, A. Newland, 1987, British Journal of Cancer.

ADOPTIVE TRANSFER OF HYPERTHYROIDISM AND AUTOIMMUNE THYROIDITIS FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION FOR CHRONIC MYELOID LEUKAEMIA

H. Prentice, O. Epstein, R. Ruggier, 1990, British journal of haematology.

Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial.

H. Prentice, F. Meunier, O. Ringdén, 1991, The Journal of antimicrobial chemotherapy.

Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).

A. Grañena, G. Gahrton, M. Labopin, 1996, Bone marrow transplantation.

Fatal hepatitis B reactivation after autologous bone marrow transplantation.

H. Prentice, M. Brenner, A. Webster, 1989, Bone marrow transplantation.

Towards a targeted, risk‐based, antifungal strategy in neutropenic patients

H. Prentice, C. Kibbler, A. Prentice, 2000, British journal of haematology.

Apparent pulmonary mycetoma following invasive aspergillosis in neutropenic patients.

H. Prentice, C. Kibbler, P. Noone, 1988, Thorax.

Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience.

H. Prentice, R. Walesby, C. Kibbler, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value

L. Foroni, H. Prentice, C. Harrison, 2000 .

Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value

L. Foroni, H. Prentice, A. Hoffbrand, 2000, British journal of haematology.

Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation.

K. Ganeshaguru, H. Prentice, A. Hoffbrand, 2001, Blood.

Chaetomium pneumonia in patient with acute myeloid leukaemia.

C. K. Campbell, H. Prentice, C. Kibbler, 1996, Journal of clinical pathology.

Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients

J. Madrigal, H. Prentice, M. Potter, 2003, Bone Marrow Transplantation.

XII/ECOG E2993 of more than 1500 patients from the international ALL trial: MRC UKALL Induction therapy for adults with acute lymphoblastic leukemia: results

S. Richards, H. Prentice, R. Chopra, 2008 .

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.

M. Tallman, S. Richards, H. Prentice, 2005, Blood.

Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.

Dylan T. Jones, K. Ganeshaguru, H. Prentice, 2002, Haematologica.

A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C.

D. Fabbro, Dylan T. Jones, K. Ganeshaguru, 2002, The hematology journal : the official journal of the European Haematology Association.

Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): delivery to acute myeloid leukemic blasts using adeno-associated virus.

H. Prentice, M. Lowdell, R. Anderson, 1997, Human gene therapy.

Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

M. Labopin, D. Blaise, J. Reiffers, 1997, Blood.

Chemotherapy versus transplants for acute myelogenous leukemia in second remission.

J. Klein, M. Oken, R. Gray, 1996, Leukemia.

Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients.

H. Prentice, S. Patel, D. Morrison, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Donor-specific bone marrow infusion after orthotopic liver transplantation

H. Prentice, B. Davidson, K. Rolles, 1994, The Lancet.

Autologous haematopoietic stem cell transplants for autoimmune disease – feasibility and transplant-related mortality

N. Schmitz, K. Sullivan, P. Brooks, 1999, Bone Marrow Transplantation.

Minimal residual disease in acute lymphoblastic leukaemia--PCR analysis of immunoglobulin gene rearrangements.

L. Foroni, H. Prentice, A. Hoffbrand, 1993, Leukemia & lymphoma.

Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine.

G. Gerrard, Dylan T. Jones, K. Ganeshaguru, 2004, Haematologica.

Infection caused by Mycobacterium chelonae: a diagnostic and therapeutic problem in the neutropenic patient.

H. Prentice, C. Kibbler, P. Mcwhinney, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy.

H. Prentice, M. Brenner, H. Blacklock, 1987, Bone marrow transplantation.

Immunocytochemical detection of breast cancer cells: a comparison of three attachment factors.

H. Prentice, A. Jones, M. Lowdell, 1997, Journal of hematotherapy.

Salivary amylase and pancreatic enzymes in serum after total body irradiation.

H. Prentice, P. Dandona, H. Blacklock, 1986, Clinical chemistry.

Yersinia enterocolitica transmission from a red cell unit 34 days old

H. Prentice, J. Barbara, P. Telfer, 1996, Transfusion medicine.

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

K. Sullivan, D. Furst, P. Emery, 2001, Annals of the rheumatic diseases.

Expression of the human major vault protein LRP in acute myeloid leukemia.

K. Ganeshaguru, H. Prentice, A. Hoffbrand, 1997, Experimental hematology.

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation

F. Mandelli, H. Prentice, P. Ljungman, 1994, The Lancet.

Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: implications for unrelated bone marrow donor selection.

M. Bunce, A. Little, J. Madrigal, 1998, Blood.

Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor‐related apoptosis‐inducing ligand

L. Foroni, Dylan T. Jones, K. Ganeshaguru, 2003, British journal of haematology.

Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance

H. Prentice, C. Kibbler, I. Hann, 2001, British journal of haematology.

Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis

H. Prentice, M. Lowdell, M. Koh, 1999, Bone Marrow Transplantation.

Abnormal alveolar macrophage populations in bone marrow transplant recipients with pneumonitis.

H. Prentice, L. Poulter, H. Milburn, 1993, The European respiratory journal.

Pneumonitis in bone marrow transplant recipients results from a local immune response

H. Prentice, R. Bois, L. Poulter, 1990, Clinical and experimental immunology.

5'nucleotidase, adenosine deaminase and purine nucleoside phosphorylase activities in acute leukaemia.

M. Greaves, H. Prentice, A. Hoffbrand, 1982, Leukemia research.

Blood product support in patients undergoing chemotherapy and autologous or allogeneic bone marrow transplantation for haematological malignancies.

H. Prentice, A. Hoffbrand, A. Mehta, 2008, Clinical and laboratory haematology.

lgG subclasses in the lungs of patients with interstitial pneumonitis following bone marrow transplantation

H. Prentice, H. Milburn, Grundy, 2012 .

B cell development and regulation after T cell-depleted marrow transplantation.

H. Prentice, M. Brenner, J. Wimperis, 1987, Journal of immunology.

Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution.

F. Lampe, H. Prentice, L. Berger, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Autologous stem cell transplantation in multiple myeloma: Results of the european group for bone marrow transplantation

H. Prentice, X. Troussard, P. Ljungman, 1995, Stem cells.

Is there a graft‐versus‐leukaemia effect in the absence of graft‐versus‐host disease in patients undergoing bone marrow transplantation for acute leukaemia?

N. Schmitz, F. Mandelli, M. Labopin, 2000, British journal of haematology.

A method for the preparation of highly purified adeno-associated virus using affinity column chromatography, protease digestion and solvent extraction.

H. Prentice, R. Anderson, A. Whiteway, 2000, Journal of virological methods.

Pulmonary cryptosporidiosis occurring in a bone marrow transplant patient.

S. Hamilton-Dutoit, H. Prentice, C. Kibbler, 1987, Scandinavian journal of infectious diseases.

HLA Down-Regulation of Cell Surface Class I Expression and Not with the CMV-Induced Function-Associated Antigen-3 (LFA-3) Induced Changes in Cell Surface Lymphocyte (CMV)-Infected Cells Correlates with Virally Natural Killer Cell Lysis of Cytomegalovirus

H. Prentice, J. Grundy, J. Fletcher, 1998 .

Second HLA-identical sibling transplants for leukemia recurrence.

M. Horowitz, R. Gale, H. Prentice, 1992, Bone marrow transplantation.

Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience.

R. Marcus, H. Prentice, R. Chopra, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients

H. Prentice, M. Potter, H. Prentice, 2001, British journal of haematology.

A technique for rapid isolation of bone marrow mononuclear cells using Ficoll‐Metrizoate and the IBM 2991 blood cell processor

G. Janossy, H. Prentice, A. Hoffbrand, 1982, British journal of haematology.

The outcome of 267 Philadelphia positive adults in the international UKALL12/ECOG E 2993 study. Final analysis and the role of allogeneic transplant in those under 50 years.

M. Tallman, H. Prentice, R. Chopra, 2003 .

Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia.

K. Ganeshaguru, H. Prentice, A. Hoffbrand, 1994, Leukemia.

The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia

H. Prentice, M. Lowdell, N. Ray, 1998, Bone Marrow Transplantation.

Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985.

R. Marcus, D. Catovsky, J. Goldman, 1987, Haematology and blood transfusion.

Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph+) acute lymphoblastic leukaemia (ALL). Results from the international ALL trial (MRC UKALLXII/ECOG E2993)

M. Tallman, S. Richards, H. Prentice, 2001 .

T cell regeneration after allogeneic bone marrow transplantation.

G. Janossy, M. Bofill, H. Prentice, 1983, Clinical and experimental immunology.

Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response

L. Foroni, H. Prentice, A. Hoffbrand, 1997, Leukemia.

Rearrangement of immunoglobulin and T cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers.

D. Campana, G. Janossy, E. Coustan-Smith, 1987, Leukemia.

Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission.

A. Hunter, H. Prentice, A. Hoffbrand, 1991, Bone marrow transplantation.

Human large granular lymphocytes induce immunoglobulin synthesis after bone marrow transplantation

H. Prentice, A. Hoffbrand, M. Brenner, 1987, European journal of immunology.

Granisetron, a selective 5-HT3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation.

A. Hunter, H. Prentice, J. Upward, 1991, Bone marrow transplantation.

Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation

W. Siegert, C. Gisselbrecht, P. Biron, 1994, The Lancet.

Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow transplantation.

H. Prentice, T. Mcelwain, M. Cornbleet, 1981, Cancer treatment reports.

IMMUNE DONORS CAN PROTECT MARROW-TRANSPLANT RECIPIENTS FROM SEVERE CYTOMEGALOVIRUS INFECTIONS

M. Hughes, H. Prentice, M. Brenner, 1987, The Lancet.

Autologous bone marrow transplantation with monoclonal antibody purged marrow for high risk acute lymphoblastic leukemia.

H. Prentice, M. Brenner, A. Burnett, 1989, Leukemia.

Central nervous system relapse in acute promyelocytic leukaemia in patients treated with all‐trans retinoic acid

Simpson, D. Grimwade, H. Prentice, 1997, British journal of haematology.

FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission

L. Foroni, H. Prentice, A. Hoffbrand, 1998, Bone Marrow Transplantation.

Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy.

H. Heslop, H. Drexler, H. Drexler, 1989, Blood.

The use of GM-CSF as an adjunct to autologous/syngeneic bone marrow transplantation: a prospective randomized controlled trial.

H. Prentice, M. Brenner, J. Grundy, 1991 .

Non‐MHC‐restricted cytotoxic cells: their roles in the control and treatment of leukaemias

A. Velardi, H. Prentice, M. Lowdell, 2001, British journal of haematology.

Herpes virus infections: clinical manifestations and therapeutic strategies in immunocompromised patients.

H. Prentice, R. Saral, W. Burns, 1984, Clinics in haematology.

Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.

H. Prentice, D. Crawford, A. Rosling, 1983, British medical journal.

The contribution of large granular lymphocytes to B cell activation and differentiation after T-cell-depleted allogeneic bone marrow transplantation.

H. Prentice, S. Stephens, M. Brenner, 1986, Transplantation.

USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIA

G. Janossy, H. Prentice, A. Hoffbrand, 1982, The Lancet.

Reactivity of Monoclonal Antibodies with Human Myeloid Precursor Cells

G. Janossy, H. Prentice, A. Hoffbrand, 1981, British journal of haematology.

Oral and Intravenous Itraconazole for Systemic Fungal Infections in Neutropenic Haematological Patients: Meeting Report

H. Prentice, B. Dupont, U. Schuler, 1999, Acta Haematologica.

Adenosine deaminase concentrations in leukaemia and lymphoma: relation to cell phenotypes.

J. Habeshaw, M. Greaves, D. Catovsky, 1981, Leukemia research.

The role of monoclonal antibodies in the prevention of graft versus host disease

G. Janossy, H. Prentice, A. Hoffbrand, 1984, Medical oncology and tumor pharmacotherapy.

Carriage of Candida species and C albicans biotypes in patients undergoing chemotherapy or bone marrow transplantation for haematological disease.

H. Prentice, C. Kibbler, P. Noone, 1989, Journal of clinical pathology.

Monoclonal Antibodies in Bone Marrow Transplantation

G. Janossy, H. Prentice, A. Hoffbrand, 1982 .

Transplantation study from the European Group for Blood and Marrow transplantation in multiple myeloma: a retrospective case-matched Allogeneic bone marrow transplantation versus autologous stem cell

R. Marcus, J. Hermans, H. Prentice, 2011 .

Validation and clinical application of molecular methods for the identification of molds in tissue.

H. Prentice, M. Potter, Timothy D McHugh, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Can lung function measurements be used to predict which patients will be at risk of developing interstitial pneumonitis after bone marrow transplantation?

R. D. du Bois, H. Prentice, H. Milburn, 1992, Thorax.

Homeostatic action of interleukin-4 on endogenous and recombinant interleukin-2-induced activated killer cell function.

H. Heslop, H. Prentice, M. Brenner, 1991, Blood.

Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation.

R. Marcus, G. Gahrton, J. Hermans, 1996, Blood.

Seroepidemiologic studies on the acquisition of antibodies to cytomegalovirus, herpes simplex virus, and human immunodeficiency virus among general hospital patients and those attending a clinic for sexually transmitted diseases

H. Prentice, G. Wannamethee, J. Grundy, 1988, Journal of medical virology.

IL‐2 infusion abrogates humoral immune responses in humans

H. Heslop, H. Prentice, M. Brenner, 1992, Clinical and experimental immunology.

Acute skin GVHD following syngeneic BMT for CLL

H. Prentice, M. Lawler, M. Deane, 1998, Bone Marrow Transplantation.

T-cell depletion in allogeneic bone marrow transplantation: progress and problems.

R. Storb, M. Martelli, R. Gale, 1989, Haematologica.

Haemolysis after T-cell depleted bone marrow transplantation involving minor AB0 incompatibility.

H. Prentice, M. Brenner, S. Knowles, 2009, Scandinavian journal of haematology.

Bone marrow transplant recipients have defective MHC-unrestricted cytotoxic responses against cytomegalovirus in comparison with Epstein-Barr virus: the importance of target cell expression of lymphocyte function-associated antigen 1 (LFA1).

H. Prentice, M. Brenner, A. V. Hoffbrand, 1992, Blood.

Understanding the Mechanisms of Cure in Acute Myeloblastic Leukaemia: Towards a Modern Immunotherapy

H. Prentice, 1992 .

Allogeneic bone marrow transplantation. Recent developments and the potential expansion of the donor pool.

H. Prentice, M. Brenner, M. McGovern, 1988, Acta oncologica.

Production of anti‐cytomegalovirus antibody following T‐cell depleted bone marrow transplant

H. Prentice, A. Hoffbrand, M. Brenner, 1986, British journal of haematology.

T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow.

D. Campana, G. Janossy, H. Prentice, 1986, Clinical and experimental immunology.

Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.

J. Klein, M. Horowitz, H. Prentice, 1996, Bone marrow transplantation.

Regeneration of humoral immunity to herpes simplex virus following T‐cell‐depleted allogeneic bone marrow transplantation

H. Prentice, M. Brenner, H. G. Prentice, 1987, Journal of medical virology.

Virological and serological diagnosis of cytomegalovirus infection in bone marrow allograft recipients

H. Prentice, A. Hoffbrand, D. Panjwani, 1985, Journal of medical virology.

Bone Marrow Transplantation in First CR of Acute Leukaemia using T-Depleted Marrow from HLA Identical Sibling Donors

G. Janossy, H. Prentice, A. Hoffbrand, 1986 .

A review of the current status and techniques of allogeneic bone marrow transplantation for treatment of leukaemia.

H. Prentice, 1983, Journal of clinical pathology.

Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells.

H. Heslop, P. Veys, H. Prentice, 1991, Blood.

Requirements for the adoptive transfer of antibody responses to a priming antigen in man.

H. Heslop, H. Prentice, M. Brenner, 1990, Journal of immunology.

In vitro analysis of the interactions of recombinant IL-2 with regenerating lymphoid and myeloid cells after allogeneic marrow transplantation.

H. Heslop, H. Prentice, M. Brenner, 1988, Journal of immunology.

Risk factors for viral reactivation following bone marrow transplantation

D. Pillay, H. Prentice, A. Webster, 2005, Annals of Hematology.

Origin of marrow stromal cells and haemopoietic chimaerism following bone marrow transplantation determined by in situ hybridisation.

H. Prentice, J. McGee, N. Athanasou, 1990, British Journal of Cancer.

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.

H. Prentice, A. Prentice, D. Warnock, 1999, British journal of haematology.

The role of immunotherapy in bone marrow transplantation for acute myeloid leukemia.

H. Prentice, M. Hamon, I. Macdonald, 1994, Progress in clinical and biological research.

Immunotherapy with interleukin 2 after ABMT in AML.

H. Prentice, C. Collis, M. Gilmore, 1993, Bone marrow transplantation.

A515U: a prodrug of acyclovir with increased oral bioavailability.

H. Prentice, P. Rees, P. Whiteman, 1986, The Journal of antimicrobial chemotherapy.

Prevention of urate nephropathy in the tumour lysis syndrome.

H. Prentice, A. Hoffbrand, N. O'connor, 1989, Clinical and laboratory haematology.

The role of immunotherapy in the treatment of acute myeloblastic leukemia: from allogeneic bone marrow transplantation to the application of interleukin 2.

H. Prentice, M. Hamon, I. Macdonald, 1993, Cancer treatment and research.

CD5-positive B cells after T cell depleted bone marrow transplantation.

H. Drexler, G. Janossy, H. Prentice, 1987, Clinical and experimental immunology.

OKT3 incubation of donor marrow for prophylaxis of acute graft-vs.-host disease (GvHD) in allogeneic bone marrow transplantation.

H. Prentice, 1982, Journal of clinical immunology.

Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.

H. Prentice, C. Kibbler, S. Seaton, 2003, The Journal of antimicrobial chemotherapy.

Host defence defects and possible approaches to their correction in the bone-marrow transplant recipient

H. Prentice, C. Kibbler, 1995 .

Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT).

F. Mandelli, G. Gahrton, M. Labopin, 1994, Leukemia.

Understanding the mechanism of cure of acute myeloid leukemia by allogeneic bone marrow transplantation: toward the application of interleukin-2 in autologous bone marrow transplantation.

H. Prentice, M. Hamon, I. Macdonald, 1994, Journal of hematotherapy.

T Depletion Using MBG6 and RFT8 Monoclonal Antibody Combination and Complement Lysis Prevents Significant Acute and Chronic GvHD in HLA Matched Allogeneic Marrow Transplants

G. Janossy, H. Prentice, A. Hoffbrand, 1985 .

Emergency response to nuclear and radiation accidents.

H. Prentice, 1989 .

THERAPEUTIC SELECTIVITY OF AND PREDICTION OF RESPONSE TO 2'-DEOXYCOFORMYCIN IN ACUTE LEUKAEMIA

A. Piga, J. Smyth, N. Russell, 1981, The Lancet.

Cytomegalovirus excretion after bone marrow transplantation cannot be predicted from the pre‐transplant level of IgG antibodies

D. Pillay, H. Prentice, H. G. Prentice, 1991, Journal of medical virology.

Malignant Neoplasms in Long-Term Survivors of Bone Marrow Transplantation

A. Tichelli, H. Prentice, P. Ljungman, 1999, Annals of Internal Medicine.

Mycobacterium tuberculosis infection following allogeneic peripheral blood stem cell transplantation

I. Kerridge, H. Prentice, M. Potter, 2003, Internal medicine journal.

Response to "Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia".

H. Prentice, R. Anderson, A. Whiteway, 1999, Human gene therapy.

Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA

Hall, H. Prentice, Xa, 1997, British journal of haematology.

Future Directions in Haematology: Beyond Multiple Myeloma

N. Russell, H. Prentice, S. Sacchi, 2005, Acta Haematologica.

Immunotherapy for Hodgkin's disease.

H. Heslop, C. Rooney, C. Bollard, 2002, Annals of hematology.

Lipid-based amphotericin B: a review of the last 10 years of use.

H. Prentice, H G Prentice, I. Hann, 2001, International journal of antimicrobial agents.

Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group.

F. Aversa, A. Nardi, H. Prentice, 1993, Blood.

Graft rejection following HLA matched T‐lymphocyte depleted bone marrow transplantation

J. Gribben, G. Janossy, J. Goldman, 1986, British journal of haematology.

RP59500 (Quinupristin/dalfopristin): three case reports of its use in infection due to Enterococcus faecium.

H. Prentice, S. Gillespie, I. Balakrishnan, 1998, The Journal of infection.

Is the measurement of virus‐specific antibody in the lungs of transplant recipients with cytomegalovirus pneumonitis of diagnostic or prognostic value?

H. Prentice, R. Bois, H. Milburn, 1988, Journal of medical virology.

RAPID DIAGNOSIS OF CYTOMEGALOVIRUS INFECTION IN IMMUNOCOMPROMISED PATIENTS BY DETECTION OF EARLY ANTIGEN FLUORESCENT FOCI

P. Griffiths, H. Prentice, D. Panjwani, 1984, The Lancet.

Respiratory infections in immunocompromised patients.

H. Prentice, M. Lipman, S. Barry, 1999, Current opinion in pulmonary medicine.

REMISSION INDUCTION WITH ADENOSINE-DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCIN IN THY-LYMPHOBLASTIC LEUKÆMIA

G. Janossy, J. Smyth, K. Ganeshaguru, 1980, The Lancet.

Immunological analysis of the skin in graft versus host disease.

G. Janossy, M. Bofill, H. Prentice, 1982, Clinical and experimental immunology.

A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation

N. Russell, J. Byrne, H. Prentice, 2006, Bone Marrow Transplantation.

Ingrowing toenails and cyclosporin

H. Prentice, J. Cox, A. Olujohungbe, 1993, The Lancet.

Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.

H. Prentice, A. McGeer, D. Caillot, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

KETOCONAZOLE VERSUS NYSTATIN PLUS AMPHOTERICIN B FOR FUNGAL PROPHYLAXIS IN SEVERELY IMMUNOCOMPROMISED PATIENTS

H. Prentice, E. Boesen, P. Noone, 1982, The Lancet.

SPECIFIC HYPERIMMUNE GLOBULIN FOR CYTOMEGALOVIRUS PNEUMONITIS

P. Griffiths, H. Prentice, H. Blacklock, 1985, The Lancet.

The pharmacokinetics of ketoconazole in severely immunocompromised patients.

H. Prentice, J. V. van Cutsem, H. Blacklock, 1982, The Journal of antimicrobial chemotherapy.

INFECTION-CONTROL ASPECTS OF BONE-MARROW TRANSPLANTATION

H. Prentice, C. Kibbler, 1994 .

Non-suppression of cortisol secretion by long term treatment with ketoconazole in patients with acute leukaemia.

H. Prentice, P. Dandona, J. Mohiuddin, 1985, Journal of clinical pathology.

PARENTERAL ACYCLOVIR THERAPY FOR HERPESVIRUS INFECTIONS IN MAN

H. Prentice, A. Hoffbrand, T. Mcelwain, 1979, The Lancet.

Impact of previous aspergillosis on the outcome of bone marrow transplantation.

D. De Bacquer, D. Bacquer, H. Prentice, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection

F. Mandelli, H. Prentice, P. Ljungman, 1997, Bone Marrow Transplantation.

Fatal invasive cerebral Absidia corymbifera infection following bone marrow transplantation

H. Prentice, B. Shaw, M. Potter, 2000, Bone Marrow Transplantation.

Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease

C. Sabin, V. Emery, H. Prentice, 1998, Bone Marrow Transplantation.

Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group for Blood and Marrow Transplantation (EBMT)

H. Einsele, A. Bosi, H. Prentice, 1998, Bone Marrow Transplantation.

Role of bronchoalveolar lavage in the evaluation of interstitial pneumonitis in recipients of bone marrow transplants.

R. D. du Bois, H. Prentice, H. Milburn, 1987, Thorax.

Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature

H. Prentice, P. Leoni, C. Kibbler, 2002, Bone Marrow Transplantation.

Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant

H. Prentice, P. Kho, 1997, Bone Marrow Transplantation.

What is the risk of transfusing micro-organisms during stem cell transplantation?

H. Prentice, C. Kibbler, 2000, Current opinion in infectious diseases.

E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemia.

D. Samson, L. Foroni, H. Prentice, 1994, Leukemia.

Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers?

A. Rimm, A. Gratwohl, M. Horowitz, 1992, Blood.

Prophylaxis and treatment of cytomegalovirus infections in the bone marrow transplant recipient.

H. Prentice, 1989, The Journal of antimicrobial chemotherapy.

Terminal Transferase Enzyme Assay and Immunological Membrane Markers in the Diagnosis of Leukaemia: a Multiparameter Analysis of 300 Cases

T. Lister, M. Greaves, G. Janossy, 1980, British journal of haematology.

Nucleoside incorporation into DNA and RNA in acute leukaemia: differences between the various leukaemia sub‐types

A. Piga, K. Ganeshaguru, H. Prentice, 1982, British journal of haematology.

Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients

H. Prentice, S. Cryz, M. Brenner, 1990 .

The Prophylaxis of Herpes Group Infections in Patients with Haematological Malignancy

H. Prentice, I. Hann, 1988 .

Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation.

M. Labopin, M. Ozsahin, A. Tichelli, 1998, International journal of radiation oncology, biology, physics.

ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION: REMOVAL OF RED BLOOD CELLS FROM DONOR MARROW AVOIDING RECIPIENT ANTIBODY DEPLETION

H. Prentice, A. Hoffbrand, D. Ma, 1982, The Lancet.

ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia

H. Prentice, A. Goldstone, L. Harewood, 2002, Leukemia.

Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients.

A. Burroughs, H. Prentice, D. Crawford, 1998, Journal of immunology.

The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties

H. Prentice, J. Chessells, S. Richards, 1998, Leukemia.

High–dose melphalan with autologous bone marrow transplant treatment of poor prognosis tumors

H. Prentice, R. Corringham, M. Gilmore, 1983, Cancer.

The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.

J. Diamond, L. Foroni, H. Prentice, 2001, Haematologica.

Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group

F. Aversa, A. Nardi, H. Prentice, 1993 .

Pulmonary cell populations in recipients of bone marrow transplants with interstitial pneumonitis.

R. D. du Bois, H. Prentice, L. Poulter, 1989, Thorax.

T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin 2.

S. Rastan, G. Asherson, H. Prentice, 1986, Cellular immunology.

Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

J Hermans, A. Gratwohl, D. Niederwieser, 2000, Blood.

Effects of recombinant interleukin-2 administration on cytotoxic function following high-dose chemo-radiotherapy for hematological malignancy.

H. Heslop, H. Prentice, M. Brenner, 1989, Blood.

Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia.

L. Foroni, H. Prentice, A. Goldstone, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblastic leukemia reveals preferential usage of J(H)-proximal variable gene segments.

L. Foroni, H. Prentice, A. Madrigal, 2001, Blood.

Association of 17p loss with late-stage or refractory disease in hematologic malignancy.

H. Prentice, A. Mehta, A. Moorman, 1994, Cancer genetics and cytogenetics.

Flow cytometric assessment of multidrug resistance (MDR) phenotype in acute myeloid leukaemia.

K. Ganeshaguru, H. Prentice, A. Hoffbrand, 1993, Leukemia & lymphoma.

Temporal dynamics of CD69 expression on lymphoid cells.

H. Prentice, M. Lowdell, N. Ray, 1997, Journal of immunological methods.

Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft

T. Barbui, M. Labopin, G. Meloni, 1999, Bone Marrow Transplantation.

European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching

M. Labopin, A. Nagler, J. Reiffers, 1997, Bone Marrow Transplantation.

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia.

J. Klein, M. Horowitz, R. Gale, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Purging of Bone Marrow

H. Prentice, M. Brenner, Grob Jp, 1987 .

T cell subpopulations, monoclonal antibodies and their therapeutic applications.

G. Janossy, H. Prentice, 1982, Clinics in haematology.

P. Griffiths, H. Prentice, A. Clark, 1999, British journal of haematology.

A role of herpes virus serology for the development of acute graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation.

H. Prentice, O. Ringdén, B. Nilsson, 1990, Bone marrow transplantation.

Standardization of the Processing of Human Bone Marrow for Allogeneic Transplantation

H. Prentice, M. Gilmore, 1986, Vox sanguinis.

A Technique for the Concentration of Nucleated Bone Marrow Cells for in vitro Manipulation or Cryopreservation Using the IBM 2991 Blood Cell Processor

H. Prentice, A. Hoffbrand, H. Blacklock, 1983, Vox sanguinis.

Intravenous and hepatic arterial infusion of high dose mitomycin C with autologous bone marrow transplantation in patients with tumour metastatic to the liver.

H. Prentice, M. Gilmore, E. Boesen, 1984, British Journal of Cancer.

Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?

N. Schmitz, F. Mandelli, M. Labopin, 2000 .

Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase

A. Piga, R. Foà, N. Russell, 1984, British journal of haematology.

TRANSFER OF A FUNCTIONING HUMORAL IMMUNE SYSTEM IN TRANSPLANTATION OF T-LYMPHOCYTE-DEPLETED BONE MARROW

H. Prentice, A. Hoffbrand, M. Brenner, 1986, The Lancet.

Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirus.

H. Heslop, H. Prentice, A. Hoffbrand, 1990, Blood.

Allogeneic bone marrow transplantation for leukemia in Europe: regional differences. Report from the Leukemia Working party of the European Group for Bone Marrow Transplantation.

A. Grañena, G. Gahrton, A. Gratwohl, 1990, Bone marrow transplantation.

The risk of early and late cytomegalovirus DNAemia associated with Campath use in stem cell transplant recipients

P. Griffiths, V. Emery, H. Prentice, 2009, Bone Marrow Transplantation.

Lingual cellulitis causing upper airways obstruction in neutropenic patients.

H. Prentice, O. Smith, B. Nazareth, 1990, BMJ.

Analysis of Rejection in HLA Matched T-Depleted Bone Marrow Transplants

J. Gribben, G. Janossy, J. Goldman, 1985 .

S. Gore, J. Goldman, H. Prentice, 1990, Transplantation.

T cell depleted bone marrow transplantation in acute myeloblastic leukaemia: the way ahead.

H. Prentice, M. Brenner, D. Gottlieb, 1989, Bone marrow transplantation.

Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation?

H. Prentice, D. Keeling, P. Sweny, 1988, Bone marrow transplantation.

A strategy for treatment of Epstein–Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells

H. Heslop, C. Rooney, C. Bollard, 2004, Cancer Gene Therapy.

Incidence of cataracts after single fraction total body irradiation: the role of steroids and graft versus host disease.

H. Prentice, C. Collis, D. Skeggs, 1993, Bone marrow transplantation.

Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia.

H. Prentice, A. Hoffbrand, P. Dandona, 1982, British medical journal.

The use of defibrotide in the management of vascular endothelial complications (VOD/HUS/TTP) of stem cell transplantation.

H. Prentice, B. Shaw, M. Potter, 1999 .

Prophylactic studies against herpes infections in severely immunocompromised patients with acyclovir.

H. Prentice, I. Hann, 1983, The Journal of infection.

In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation.

Anthony, H. Heslop, H. Prentice, 1989, Blood.

Plasma soluble interleukin 2 receptor levels in patients with malignant lymphoma are correlated with disease activity but not cellular immunosuppression.

H. Prentice, E. Boesen, M. Hamon, 1993, Leukemia & lymphoma.

Valproic-acid-induced pancytopenia and Coombs test positivity

H. Prentice, U. Dilmen, D. Senses, 1991, The Lancet.

Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.

H. Prentice, J. Grundy, J. Fletcher, 1998, Journal of immunology.

Recurrence of acute leukemia in donor cells after bone marrow transplantation: documentation by in situ DNA hybridization.

H. Prentice, A. Hoffbrand, M. Mouratidou, 1993, Bone marrow transplantation.

Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

T. Barbui, M. Labopin, G. Meloni, 1999, Bone marrow transplantation.

Streptococcus mitis and ARDS in neutropenic patients

H. Prentice, A. V. Hoffbrand, C. Kibbler, 1991, The Lancet.

Immunological monitoring of residual disease in treated thymic acute lymphoblastic leukaemia.

G. Janossy, H. Prentice, A. Hoffbrand, 1981, Leukemia research.

Identification of non-naïve CD4+CD45RA+ T cell subsets in adult allogeneic haematopoietic cell transplant recipients

H. Prentice, M. Potter, P. Travers, 2003, Bone Marrow Transplantation.

Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients.

H. Prentice, 1983, The Journal of antimicrobial chemotherapy.

Successful treatment of parvovirus B19 infection and red cell aplasia occurring after an allogeneic bone marrow transplant.

H. Prentice, U. Popat, W. Knowles, 1995, Bone marrow transplantation.

Which febrile neutropenic patients are suitable for outpatient management

H. Prentice, C. Kibbler, 1997 .

The results of a randomized trial of empirical antibiotic treatment in febrile neutropenic patients with four beta-lactam/aminoglycoside combinations.

H. Prentice, P. Noone, H. Blacklock, 1983, The Journal of antimicrobial chemotherapy.

Value of routine surveillance cultures for detection of CMV pneumonitis following bone marrow transplantation.

D. Pillay, H. Prentice, A. Webster, 1993, Bone marrow transplantation.

Granisetron in the prevention of irradiation-induced emesis.

H. Prentice, C. Collis, M. Hamon, 1995, Bone marrow transplantation.

REMISSION INDUCTION IN ACUTE MYELOID LEUKAEMIA WITH ORAL ETOPOSIDE

H. Prentice, J. Evans, 1982, The Lancet.

Antithrombin III in the diagnosis of infection in febrile neutropenic patients

H. Prentice, P. Noone, C. Kibbler, 1988, Journal of clinical microbiology.

Treatment of cyclophosphamide-induced cystitis with prostaglandin E2.

H. Prentice, P. Dandona, H. Blacklock, 1984, Annals of internal medicine.

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group.

F. Mandelli, H. Prentice, P. Ljungman, 1994, Lancet.

Rapid diagnosis of cytomegalovirus infection.

P. Griffiths, R. D. du Bois, H. Prentice, 1985, Lancet.

Philadelphia chromosome plus ve patients with adult acute lymphoblastic leukaemia (ALL), early results from the international ALL trial (MRC UKALL-XII/ECOG E2993).

D. Neuberg, M. Tallman, S. Richards, 1999 .

Detection of adeno-associated virus type 2 in sorted human bone marrow progenitor cells.

H. Prentice, M. Lowdell, R. Anderson, 1997, Experimental hematology.

Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions.

Robert Anderson, H. Prentice, A. Whiteway, 2003, Journal of virological methods.

Liposomal amphotericin B in neutropenic patients

H. Prentice, 1993 .

Adjuvant use of GM-CSF in invasive aspergillosis.

H. Prentice, M. Potter, C. Kibbler, 1998 .

VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.

H. Prentice, M. Lowdell, M. Hamon, 1995, Experimental hematology.

Hepatocyte progenitor cells in massive hepatic necrosis

J. North, H. Prentice, M. Lowdell, 2003 .

Antiviral therapy in the immunocompromised patient.

H. Prentice, I. Hann, 1985, British medical bulletin.

Sequential studies on the role of mitoxantrone in the treatment of acute leukemia.

H. Prentice, J. Wimperis, G. Robbins, 1983, Investigational new drugs.

Correlation of immunophenotype with rearrangement of T cell antigen receptor beta and gamma genes in acute lymphoblastic leukemia of adults.

D. Campana, G. Janossy, J. Norton, 1988, Leukemia.

MYELODYSPLASIA AND ACUTE MYELOID LEUKAEMIA FOLLOWING BONE MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKAEMIA: SECONDARY LEUKAEMIA OR STEM‐CELL RELAPSE?

H. Prentice, L. Secker-Walker, D. Whitmore, 1989, British journal of haematology.

Multidrug Resistance in Acute Leukaemia: A Comparative Study of Immunocytochemical and RNA Slot Blot Detection of P-glycoprotein Expression.

K. Ganeshaguru, H. Prentice, A. Hoffbrand, 1991, Leukemia & lymphoma.

INFECTIONS OF THE IMMUNOCOMPROMISED HOST

H. Prentice, C. Kibbler, 1993 .

ACUTE LYMPHOBLASTIC LEUKAEMIA IN ADULTS

H. Prentice, J. Grob, 1986, The Lancet.

Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients.

H. Prentice, S. Cryz, M. Brenner, 1990, Blood.

Rapid recovery of helper activity following T cell depleted allogeneic marrow transplant.

H. Drexler, H. Prentice, A. Hoffbrand, 1987, Clinical and experimental immunology.

Intravenous and hepatic arterial infusion of high dose mitomycin C with autologous bone marrow transplantation in patients with tumour metastatic to the liver.

H. Prentice, M. Gilmore, R. Dick, 1984, British Journal of Cancer.